MLTX
Price
$47.69
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
33 days until earnings call
SYRE
Price
$27.48
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
28 days until earnings call
Ad is loading...

MLTX vs SYRE

Header iconMLTX vs SYRE Comparison
Open Charts MLTX vs SYREBanner chart's image
MoonLake Immunotherapeutics
Price$47.69
Change-$0.00 (-0.00%)
Volume$1.19M
CapitalizationN/A
Spyre Therapeutics
Price$27.48
Change-$0.00 (-0.00%)
Volume$289.41K
CapitalizationN/A
View a ticker or compare two or three
MLTX vs SYRE Comparison Chart
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MLTX vs. SYRE commentary
Oct 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a StrongBuy and SYRE is a StrongSell.

COMPARISON
Comparison
Oct 11, 2024
Stock price -- (MLTX: $47.87 vs. SYRE: $27.50)
Brand notoriety: MLTX and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 342% vs. SYRE: 50%
Market capitalization -- MLTX: $3.18B vs. SYRE: $1.45B
MLTX [@Biotechnology] is valued at $3.18B. SYRE’s [@Biotechnology] market capitalization is $1.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, SYRE is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 4 TA indicator(s) are bullish while SYRE’s TA Score has 3 bullish TA indicator(s).

  • MLTX’s TA Score: 4 bullish, 6 bearish.
  • SYRE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than SYRE.

Price Growth

MLTX (@Biotechnology) experienced а -7.62% price change this week, while SYRE (@Biotechnology) price change was -0.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

MLTX is expected to report earnings on Mar 24, 2025.

SYRE is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.18B) has a higher market cap than SYRE($1.45B). SYRE YTD gains are higher at: 27.788 vs. MLTX (-20.732). MLTX has higher annual earnings (EBITDA): -78.35M vs. SYRE (-172.92M). MLTX has more cash in the bank: 520M vs. SYRE (426M). SYRE has less debt than MLTX: SYRE (0) vs MLTX (3.34M). MLTX (0) and SYRE (0) have equivalent revenues.
MLTXSYREMLTX / SYRE
Capitalization3.18B1.45B219%
EBITDA-78.35M-172.92M45%
Gain YTD-20.73227.788-75%
P/E RatioN/A2.70-
Revenue00-
Total Cash520M426M122%
Total Debt3.34M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
48
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXSYRE
RSI
ODDS (%)
Bearish Trend 2 days ago
58%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL229.543.77
+1.67%
Apple
SPY577.143.97
+0.69%
SPDR® S&P 500® ETF Trust
GME20.50-0.21
-1.01%
GameStop Corp
TSLA241.05-3.45
-1.41%
Tesla
BTC.X60582.100000-1549.867200
-2.49%
Bitcoin cryptocurrency

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with SYRE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-3.97%
SYRE - MLTX
41%
Loosely correlated
-1.36%
REPCF - MLTX
37%
Loosely correlated
N/A
ARDX - MLTX
36%
Loosely correlated
-1.68%
PGEN - MLTX
36%
Loosely correlated
-0.02%
AXSM - MLTX
36%
Loosely correlated
-1.53%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with ACIU. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then ACIU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
-1.36%
ACIU - SYRE
51%
Loosely correlated
+2.42%
SNPX - SYRE
47%
Loosely correlated
-0.67%
PMN - SYRE
44%
Loosely correlated
N/A
GOSS - SYRE
41%
Loosely correlated
-0.98%
MLTX - SYRE
41%
Loosely correlated
-3.97%
More